(Q83322829)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690523%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Mitoxantrone, vinblastine and CCNU: long-term follow-up of patients treated for advanced and poor-prognosis Hodgkin's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690523%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

3

Peter H Wiernik

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690523%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

4

Janice P Dutcher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690523%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Doru T Alexandrescu

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690523%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Sirisha Karri

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690523%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690523%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690523%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690523%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690523%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

641-656

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690523%20AND%20SRC:MED&resulttype=core&format=json

Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Early stage Hodgkin's disease: can we have our cake and eat it, too?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

The superiority of CCNU in the treatment of advanced Hodgkin's disease: Cancer and Leukemia Group B Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Age of onset evidence for anticipation in familial non-Hodgkin's lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Intracranial Hodgkin's disease in two patients with familial Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Intensive salvage therapy with high-dose chemotherapy for patients with advanced Hodgkin's disease in relapse or failure after initial chemotherapy: results of the Groupe d'Etudes des Lymphomes de l'Adulte H89 Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Results of treatment with ABVD in C-MOPP-resistant Hodgkin's disease (author's transl)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Salvage Chemotherapy with ABVD in MOPP-Resistant Hodgkin's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (AB

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Comparison of high-dose therapy and autologous stem-cell transplantation with conventional therapy for Hodgkin's disease induction failure: a case-control study. Société Francaise de Greffe de Moelle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Cisplatin-CBV with autologous bone marrow transplantation for relapsed Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

High-dose chemotherapy followed by autologous hematopoietic rescue for Hodgkin's disease patients following first relapse after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

High-dose therapy and autologous stem cell rescue for patients with Hodgkin's disease in first relapse after chemotherapy: results from the EBMT. Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Peripheral-blood stem-cell transplantation versus autologous bone marrow transplantation in Hodgkin's and non-Hodgkin's lymphomas: a new matched-pair analysis of the European Group for Blood and Marrow Transplantation Registry Data. Lymphoma Working

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

The value of augmented preparative regimens combined with an autologous bone marrow transplant for the management of relapsed or refractory Hodgkin disease: a Southwest Oncology Group phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Autologous stem cell transplantation for Hodgkin's disease: busulfan, melphalan and thiotepa compared to a radiation-based regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

High-dose therapy and autologous stem cell transplantation in relapsed and refractory Hodgkin's disease: outcome based on a prognostic model

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Autologous stem cell transplantation for primary refractory Hodgkin's disease: results and clinical variables affecting outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Hodgkin's disease coexisting with myelodysplastic syndrome prior to therapy: a case report and a review of the association of Hodgkin's disease with stem cell disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500376241

10.1080/10428190500376241

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16690523%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference